Thomas Herzog
MD
Paul and Carolyn Flory Endowed Professor, Obstetrics and Gynecology
University of Cincinnati Cancer Center

Dr. Thomas Herzog is a Gyn Oncologist who served the Deputy Director of the University of Cincinnati Cancer Center from 2015 to 2024 and also as Vice-Chair of Quality and Safety for Obstetrics and Gynecology, University of Cincinnati College of Medicine. From 2004 to 2014 he was the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics at Columbia University. He also was the Fellowship Director in Gynecologic Oncology for Columbia & Cornell Universities and New York Presbyterian Hospitals. Prior to 2004, he was as an Associate Professor, and the Director of the Fellowship Training Program at Washington University in St. Louis.

He currently serves as the President of The GOG-Foundation after his election in 2023, and he has served as Treasurer of the GOG-Foundation and as Associate-Director of GOG Partners. Dr. Herzog has authored/co-authored over 330 peer-reviewed articles and lectures extensively nationally and internationally. As a physician scientist, he has accrued over 1 million dollars in grant funding He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, Hematology Oncology Times, Frontiers in Oncology and others. He served as Editor–in chief of Women’s Oncology Review and Gynecologic Oncology Research to Practice. Dr. Herzog has served on the board of directors or leadership council of the Society of Gynecologic Oncology, the Foundation for Women’s Cancer, Board of Governors for the American College of Surgeons, American Board of Obstetrics and Gynecology, and the International Gynecologic Cancer Society.

Sessions

Register
General Session

Debate: Front Line Maintenance Therapy for Advanced Ovarian Cancer: Everyone Should Be Offered PARPi

Saturday, November 02, 2024
2:15 PM - 2:30 PM
General Session

Debate: Front Line Maintenance Therapy for Advanced Ovarian Cancer: Everyone Should Be Offered PARPi vs. New Opportunities Beyond PARPi – DISCUSSION

Saturday, November 02, 2024
2:45 PM - 2:55 PM